Dr. Skikne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2413 West 124th Street
Leawood, Kansas
Leawood, KS 66209Phone+1 913-522-7975- Is this information wrong?
Education & Training
University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 1977 - 1979
University of the WitwatersrandClass of 1969
Certifications & Licensure
KS State Medical License 1978 - 2024
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia Start of enrollment: 2007 Sep 11
- Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma Start of enrollment: 2008 Aug 12
- Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine Start of enrollment: 2012 Feb 07
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsPopulation Pharmacokinetics of Oral Azacitidine, and Exposure-Response Analysis in Acute Myeloid Leukemia.Allison Gaudy, Eric Laille, Rochelle Bailey, Simon Zhou, Barry Skikne, C L Beach> ;Clinical Pharmacology and Therapeutics. 2023 Oct 1
- 2 citationsOral azacitidine modulates the bone marrow microenvironment in patients with acute myeloid leukaemia in remission: A subanalysis from the QUAZAR AML-001 trial.Daniel L Menezes, Wendy L See, Alberto Risueño, Kao Tai Tsai, Jae K Lee, Johnny Ma, Rida Khan, Thomas Prebet, Barry Skikne, C L Beach, Anjan Thakurta, Anita Gandhi> ;British Journal of Haematology. 2023 Jun 1
- Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the...Andrew H Wei, Gail J Roboz, Herve Dombret, Hartmut Dohner, Andre C Schuh, Pau Montesinos, Dominik Selleslag, Sergey N Bondarenko, Thomas Prebet, Yinzhi Lai, Barry Skik...> ;Haematologica. 2023 Oct 1
- Join now to see all
Abstracts/Posters
- LAG3 Inhibition Decreases AML-Induced Immunosuppression and Improves T Cell-Mediated KillingBarry S. Skikne, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase...Barry S. Skikne, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Remembering James Cook, Oncology Researchers Receive 2020 NIH Director’s New Innovator Awards, and MoreFebruary 1st, 2021
Hospital Affiliations
The University of Kansas HospitalKansas City, Kansas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
